BioMarin to Highlight Breadth of Innovative Development Pipeline

At Analyst and Investor Day on December 10th in New York

CheckOrphan—December 10, 2014

BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) will host an Analyst and Investor Day from 8am (ET) to 1pm (ET) on Wednesday, December 10, 2014 at The Plaza Hotel. BioMarin management and external experts will provide an update to the investment community on the Company's development portfolio, which is focused on innovative therapies to treat rare and ultra-rare diseases.

External key opinion leaders scheduled to present include:

Interested parties may access a live audio webcast and slides of the presentations via the investor section of the BioMarin website.  A replay of the meeting will be archived on the site for at least one week.


Find a Physician

Conditions & Treatments

adult child
Select A Body Part

Complete Listing »

Media Contacts

Tracy Hickenbottom
Monique Irons


Social Media Contacts

Andrew Worob
Otis Gamboa